BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 27277749)

  • 1. Clinical significance of RET mutation screening in a pedigree of multiple endocrine neoplasia type 2A.
    Ying R; Feng J
    Mol Med Rep; 2016 Aug; 14(2):1413-7. PubMed ID: 27277749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The clinical patterns and RET proto-oncogene in fifteen multiple endocrine neoplasia type 2A pedigrees].
    Zhou YL; Zhu SX; Li JJ; Liu JB; Yin M; Xiao BY; Yu CL; Wang LM; Gu LQ; Cui B; Ning G; Li XY; Zhao YJ
    Zhonghua Nei Ke Za Zhi; 2007 Jun; 46(6):466-70. PubMed ID: 17663821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B.
    Zhou Y; Zhao Y; Cui B; Gu L; Zhu S; Li J; Liu J; Yin M; Zhao T; Yin Z; Yu C; Chen C; Wang L; Xiao B; Hong J; Zhang Y; Tang Z; Wang S; Li X; Ning G
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):570-6. PubMed ID: 17573899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mutation of the RET proto-oncogene in type 2A multiple endocrine neoplasia Chinese families and the application of pentagastrin stimulation test in diagnosis and follow-up].
    Yao B; Liu X; Chen X; Dong TT; Liang H; Weng JP
    Zhonghua Nei Ke Za Zhi; 2007 Nov; 46(11):914-8. PubMed ID: 18261274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [DelD631: a novel mutation of the RET proto-oncogene in multiple endocrine neoplasia type 2A (MEN2A)].
    Yao B; Liu X; Dong TT; Chen X; Huang ZM; Weng JP
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1962-5. PubMed ID: 17923033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of RET proto-oncogene mutations in two pedigrees affected with multiple endocrine neoplasia type 2A].
    Weng Y; Li F; Zhang S; Cheng H; Yan L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Oct; 35(5):648-652. PubMed ID: 30298487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical features and mutations of RET proto-oncogene in a pedigree affected with type 2A multiple endocrine neoplasia].
    Zhang Y; Zheng X; Cheng L; Ma S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Feb; 34(1):106-109. PubMed ID: 28186607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogene.
    Peppa M; Boutati E; Kamakari S; Pikounis V; Peros G; Panayiotides IG; Economopoulos T; Raptis SA; Hadjidakis D
    Eur J Endocrinol; 2008 Dec; 159(6):767-71. PubMed ID: 18805915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
    Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synergy of germline C634Y and V292M RET mutations in a northern Chinese family with multiple endocrine neoplasia type 2A.
    Yang Z; Qi X; Gross N; Kou X; Bai Y; Feng Y; Wang B; Zafereo ME; Li G; Sun C; Li H; Chen X; Huang Z
    J Cell Mol Med; 2020 Nov; 24(22):13163-13170. PubMed ID: 32989896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple endocrine neoplasia type 2A due to an exon 8 (G533C) mutation in a large North American kindred.
    Castro MR; Thomas BC; Richards ML; Zhang J; Morris JC
    Thyroid; 2013 Dec; 23(12):1547-52. PubMed ID: 23461807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutation (D631del) of the RET gene was associated with MEN2A in a Chinese pedigree.
    Yao B; Liu X; Liang H; Dong TT; Huang ZM; Chen X; Weng JP
    Endocr J; 2009; 56(1):99-104. PubMed ID: 18845906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Description of the first two seemingly unrelated Greek Cypriot families with a common C618R RET proto-oncogene mutation.
    Neocleous V; Passalaris T; Spanou E; Kitsios P; Skordis N; Deltas CC
    Genet Test; 2004; 8(2):163-8. PubMed ID: 15345114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RET mutation status in medullary thyroid cancer(MTC) patients and the significance of genetic screening for mutations in their immediate relatives--a preliminary report.
    Menon MM; Simha MR
    Indian J Pathol Microbiol; 2005 Apr; 48(2):161-5. PubMed ID: 16758654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [RET gene cys 634 trp mutation in a multiple endocrine neoplasia type 2A kindred].
    Ning ZW; Wang O; Pei Y; Meng XW; Xing XP; Xia WB; Li M; Zhou XY; Zeng ZP
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):799-802. PubMed ID: 17260470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic testing for multiple endocrine neoplasia type 2.
    Păun DL; Mohora M; Duţă C; Dumitrache C
    Rom J Intern Med; 2008; 46(2):159-63. PubMed ID: 19284088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic correlation between RET proto-oncogene mutation, imaging techniques, biochemical markers and morphological examination in MEN2A syndrome: case report and literature review.
    Sovrea AS; Dronca E; Galatâr M; Radian S; Vornicescu C; Georgescu C
    Rom J Morphol Embryol; 2014; 55(2):389-400. PubMed ID: 24969991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
    Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different RET gene mutation-induced multiple endocrine neoplasia type 2A in 3 Chinese families.
    Liu Q; Tong D; Yuan W; Liu G; Yuan G; Lan W; Zhang D; Zhang J; Huang Z; Zhang Y; Jiang J
    Medicine (Baltimore); 2017 Jan; 96(3):e5967. PubMed ID: 28099363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of RET Mutations and Evaluation of Treatment Approaches in Hereditary Medullary Thyroid Carcinoma in Turkey.
    Aydoğan Bİ; Yüksel B; Tuna MM; Navdar Başaran M; Akkurt Kocaeli A; Ertörer ME; Aydın K; Güldiken S; Şimşek Y; Cihan Karaca Z; Yılmaz M; Aktürk M; Anaforoğlu İ; Kebapçı N; Duran C; Taşlıpınar A; Kulaksızoğlu M; Gürsoy A; Dağdelen S; Erdoğan MF
    J Clin Res Pediatr Endocrinol; 2016 Mar; 8(1):13-20. PubMed ID: 26758973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.